Close Menu

NEW YORK – Molecular diagnostics firm Vikor Scientific has made a strategic investment in California-based Quantgene to accelerate the commercialization of Quantgene's Serenity, a personalized preventive medicine service that includes the use of whole-genome sequencing, artificial intelligence-informed liquid biopsy cancer screening, and other in-depth health profiling.

The companies made the announcement on Wednesday during the SCBIO 2021 annual meeting. Financial details of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.